Aesica’s Cramlington Site to Undergo Green Initiative

UK Green Investment Bank plc (GIB) and John Laing Investments Ltd. (JLI) have committed £50 million of equity to a new £137 million renewable energy facility in Cramlington, Northumberland that will generate 223 GWh of renewable electricity annually. It is expected to reduce greenhouse gas emissions equivalent to taking 25,000 cars off the road during its lifetime.
 
Aesica Pharmaceuticals, together with another pharma company, will benefit from its output, and green electricity will be routed to Aesica’s Cramlington site located in an adjacent industrial estate.
 
The construction of the plant will be undertaken by a joint venture between Burmeister & Wain Energy A/S (BWE) and Burmeister & Wain Scandinavian Contractors A/S (BWSC). BWSC will operate the plant upon completion. As many as 250 jobs are expected to be created during the construction process, while 25 permanent positions will be maintained at the operational facility.
 
Ian Muir, managing director at Aesica said, “Our company is committed to best environmental practice and indeed our Cramlington site complies in full with ISO 14001and all appropriate environmental legislation. Consequently, we are always on the lookout for maximizing the use of green, environmentally friendly energy. We are therefore delighted to receive our energy supply moving forwards from the biomass combined heat and power plant and to playing our role through this initiative in reducing greenhouse emissions.”